Literature DB >> 33755882

Neurological manifestations of thrombotic microangiopathy syndromes in adult patients.

Erika L Weil1, Alejandro A Rabinstein2.   

Abstract

The objective of this study was to compare the frequency and severity of neurologic manifestations in adult patients diagnosed with thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS) and atypical HUS (aHUS). This is a retrospective cohort study of adult patients diagnosed with TTP, HUS and atypical HUS hospitalized at a tertiary center between January 2004 and October 2016. A total of 42 TTP, 16 HUS and 20 aHUS episodes were reviewed to collect clinical, laboratory and radiographic data, as well as information regarding long-term functional outcome. Neurologic symptoms are more common in patients with TTP and HUS as compared to aHUS (p < 0.001 and p = 0.002, respectively). Encephalopathy occurred in 29 TTP (69%) and 11 HUS (68%) episodes. Focal deficits were only observed in patients with TTP (n = 8 [19%]). Seizures were most commonly seen in HUS patients (n = 8 [50%]). Posterior reversible encephalopathy syndrome (PRES) was the most common neuroimaging finding in these syndromes; ischemic infarcts and hemorrhages occurred uncommonly. There was no correlation between presence of neurologic symptoms or neuroimaging abnormalities and poor outcome. Patients with TTP and HUS appear to have a similar spectrum of neurologic manifestations, whereas neurologic involvement is less common in aHUS. PRES is the most common imaging abnormality, and may present atypically. Despite presence of neurologic symptoms or neuroimaging abnormalities, patients with thrombotic microangiopathy (TMA) tend to have favorable long-term outcomes.

Entities:  

Keywords:  Encephalopathy; Hemolytic uremic syndrome; Posterior reversible encephalopathy syndrome (PRES); Seizures; Thrombotic thrombocytopenic purpura

Mesh:

Year:  2021        PMID: 33755882     DOI: 10.1007/s11239-021-02431-5

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  24 in total

1.  The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak.

Authors:  Tim Magnus; Joachim Röther; Olga Simova; Maria Meier-Cillien; Jonas Repenthin; Fabian Möller; Joystone Gbadamosi; Ulf Panzer; Martina Wengenroth; Christian Hagel; Stefan Kluge; Rolf K Stahl; Karl Wegscheider; Peter Urban; Bernd Eckert; Markus Glatzel; Jens Fiehler; Christian Gerloff
Journal:  Brain       Date:  2012-04-26       Impact factor: 13.501

Review 2.  Atypical hemolytic-uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2009-10-22       Impact factor: 91.245

3.  The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings.

Authors:  N Banatvala; P M Griffin; K D Greene; T J Barrett; W F Bibb; J H Green; J G Wells
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

Review 4.  Syndromes of thrombotic microangiopathy.

Authors:  James N George; Carla M Nester
Journal:  N Engl J Med       Date:  2014-08-14       Impact factor: 91.245

5.  Clinical and radiologic features of encephalopathy during 2011 E coli O111 outbreak in Japan.

Authors:  Jun-ichi Takanashi; Hiromichi Taneichi; Takako Misaki; Yuichiro Yahata; Akihisa Okumura; Yoh-ichi Ishida; Toshio Miyawaki; Nobuhiko Okabe; Tetsutaro Sata; Masashi Mizuguchi
Journal:  Neurology       Date:  2014-01-17       Impact factor: 9.910

Review 6.  Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome.

Authors:  R L Siegler
Journal:  J Pediatr       Date:  1994-10       Impact factor: 4.406

7.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

8.  Diffusion-weighted imaging findings in hemolytic uremic syndrome with central nervous system involvement.

Authors:  Irene Toldo; Renzo Manara; Paola Cogo; Stefano Sartori; Luisa Murer; Pier Antonio Battistella; Anna Maria Laverda
Journal:  J Child Neurol       Date:  2008-12-12       Impact factor: 1.987

Review 9.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

Review 10.  Atypical hemolytic uremic syndrome.

Authors:  Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Orphanet J Rare Dis       Date:  2011-09-08       Impact factor: 4.123

View more
  1 in total

1.  Neurological manifestations in thrombotic microangiopathy: Imaging features, risk factors and clinical course.

Authors:  José Thiago de Souza de Castro; Simone Appenzeller; Marina Pereira Colella; Gabriela Yamaguti-Hayakawa; Erich Vinícius De Paula; Joyce Annichinno-Bizzachi; Fernando Cendes; Reis Fabiano; Fernanda Andrade Orsi
Journal:  PLoS One       Date:  2022-09-21       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.